人民卫生出版社系列期刊
ISSN 2096-2738 CN 11-9370/R

中国科技核心期刊(中国科技论文统计源期刊)
2020《中国学术期刊影响因子年报》统计源期刊

新发传染病电子杂志 ›› 2020, Vol. 5 ›› Issue (4): 239-242.doi: 10.19871/j.cnki.xfcrbzz.2020.04.005

• 论著 • 上一篇    下一篇

中西医结合疗法治疗31例重型新型冠状病毒肺炎临床疗效分析

宋玉燕1, 黄长先1, 周璐1, 张英2, 张安3, 詹柱3, 李群堂4, 邱敏5   

  1. 1.重庆市公共卫生医疗救治中心歌乐山院区重症医学科,重庆 400036;
    2.重庆市公共卫生医疗救治中心病理科,重庆 400036;
    3.重庆医科大学附属第二医院重症医学科,重庆 400010;
    4.重庆市中医院治未病科,重庆 400021;
    5.重庆市中医院肿瘤科,重庆 400021
  • 收稿日期:2020-08-15 出版日期:2020-11-30 发布日期:2020-12-31
  • 通讯作者: 邱敏,Email:13983922797@163.com
  • 基金资助:
    1.新型冠状病毒感染肺炎疫情应急科技攻关专项(cstc2020jscx-fyzxX0012);2.基于多模态大数据融合的新冠肺炎患者重症转化风险预警模型的研究与应用(cstc2020jscx-fyzxX0023);2.重庆市卫生健康委员会“新冠肺炎防控应急科研专项”(2020NCPZX04)

Clinical efficacy of combination therapy of traditional Chinese, western medicine on31severe ill patients with coronavirus disease2019

Song Yuyan1, Huang Changxian1, Zhou Lu1, Zhang Ying2, Zhang An3, Zhan Zhu3, Li Quntang4, Qiu Min5   

  1. 1. Department of critical medicine,Geleshan Hospital District,Chongqing public health medical center,Chongqing 400036;
    2. Department of pathology,Chongqing public health medical center,,Chongqing 400036;
    3. Department of critical medicine,The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China;
    4. Department of preventive medicine,Chongqing traditional Chinese Medicine Hospital,Chongqing 400021,China;
    5. Department of oncology,Chongqing traditional Chinese Medicine Hospital,Chongqing 400021,China
  • Received:2020-08-15 Online:2020-11-30 Published:2020-12-31

摘要: 目的 分析中西医联合疗法与单纯西医疗法治疗新型冠状病毒肺炎(COVID-19)重型患者的临床疗效,明确中医药在重症COVID-19患者中的治疗价值。方法 回顾性分析重庆市公共卫生医疗救治中心收治的31例COVID-19重型患者根据治疗方案分为西医组和中西医结合组。西医组给予对症支持、氧疗、抗病毒等治疗。中西医结合组在西医组治疗基础上,给予中药序贯疗法治疗。观察比较两组患者入ICU后临床疗效指标,包括住院天数、入住ICU天数、住院费用、使用高流量氧疗时间、使用无创通气时间、核酸转阴时间、危重转化率及实验室和影像学检查指标。结果 ①中西医结合组患者相较于西医组患者在住院天数方面明显缩短,差异有统计学意义(P<0.05);②在入ICU后第14天,中西医结合组患者相较于西医组患者在氧合指数、前白蛋白等指标的改善方面更具优势,比较差异有统计学意义(P<0.05)。结论 中西医联合治疗可改善住院治疗期间氧合指数,并明显缩短COVID-19重型患者的住院时间。

关键词: 新型冠状病毒肺炎, 中西医结合疗法, 临床疗效, 回顾性分析

Abstract: Objective Aiming to clarify the therapeutic value of traditional Chinese medicine in the treatment of patients with severe coronavirus disease 2019 (COVID-19),a retrospective analysis was performed to compare the clinical efficacy of the combination of traditional Chinese and western medicine (Combination group) and western medicine alone (Western group).Methods We enrolled 31 severe COVID-19 patients who were admitted to the Chongqing Public Health Medical Center,and the clinical data about epidemiological history,symptoms,signs,laboratory and imaging examinations were collected.The patients were divided into two groups according to the treatment.The patients in Western group were given symptomatic support,oxygen therapy,antiviral and other treatments;The patients in Combination group were given sequential treatment of traditional Chinese medicine based on the treatments of the Western group.The clinical efficacy indicators after admission to the ICU of patients in two groups were compared,including:length of hospital stay,length of ICU stay,costs of hospitalization,time of using high-flow oxygen therapy,time of using non-invasive ventilation,time of nucleic acid converting to negative,critical conversion Rate,and laboratory and imaging indicators.Results ① The length of hospital stay in the Combination group was significantly less than the Western group (P<0.05).② On the 14th day after ICU admission,the patients in the Combination group had higher oxygenation index and prealbumin than those in the Western group.Conclusions The combination therapy of traditional Chinese and western medicine can improve the oxygenation index during hospitalization,and significantly reduce the length of hospitalization in severe ill patients with COVID-19.

Key words: Coronavirus disease 2019, Chinese and Western medicine combination therapy, Clinical efficacy, Retrospective analysis